| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut National de la Santé et de la Recherche Médicale (INSERM) (Z.M., T.S., J.B., S.T., A.T.), Université Paris Descartes and Assistance Publique-H
pitaux de Paris, Paris Cardiovascular Research Center (PARCC), 75015 Paris, France; Department of Pharmacology (T.S.), Assistance Publique-H
pitaux de Paris (AP-HP), Hôpital Saint-Antoine-Unité de Recherche Clinique de lEST Parisien, and Université Pierre et Marie Curie, 75012 Paris, France; Centre dInvestigation Clinique et Centre de Ressources Biologiques (J.B.), AP-HP, Hôpital Bichat, 75018 Paris, France; INSERM (K.C.), Unité Mixte de Recherche en Santé Unit 872, University Pierre et Marie Curie, 75012 Paris, France; Medical Research Council (N.J.W.), Epidemiology Unit, CB1 9NL Cambridge, United Kingdom; Department of Public Health and Primary Care (R.L., K.-T.K.), University of Cambridge, CB3 0DS Cambridge, United Kingdom; and Departments of Cardiology and Vascular Medicine (S.M.B.), Academic Medical Center, 1100 D Amsterdam, The Netherlands
Address all correspondence and requests for reprints to: Ziad Mallat, M.D., Ph.D., Institut National de la Santé et de la Recherche Médicale Unit 689, Hôpital Lariboisière, 75010 Paris, France. E-mail: ziad.mallat{at}larib.inserm.fr.
Context: Recent studies reported that retinol-binding protein 4 (RBP4) has a causal role in insulin resistance and suggested that its circulating levels may predict cardiovascular disease. However, the latter assumption has not yet been tested.
Objective: We assessed the value of RBP4 measurement in the prediction of incident coronary artery disease (CAD).
Design: We conducted a nested case-control study of incident CAD (n = 1036 cases vs. n = 1889 controls) selected from among 25,336 participants of the EPIC-Norfolk study.
Setting: Healthy men and women, aged between 45 and 79 yr, were recruited from age-sex registers of general practices in Norfolk.
Patients and Other Participants: Participants completed a baseline questionnaire survey between 1993 and 1997, attended a clinic visit, and were followed for an average of 6 yr. Cases (n = 1036) were participants who developed CAD during the follow-up. Controls (n = 1889) matched by age, sex, and enrollment time remained free of any CAD during follow-up.
Main Outcomes Measure: Risk of incident fatal or nonfatal CAD according to RBP4 quartiles was assessed.
Results: RBP4 levels were higher in cases than in controls. RBP4 levels correlated weakly with body mass index, waist-to-hip ratio, systolic and diastolic blood pressure, and total and low-density lipoprotein-cholesterol and were inversely associated with C-reactive protein concentrations. The strongest correlation was found with triglycerides. The risk of incident CAD was associated with increasing quartiles of RBP4 levels (P = 0.03). However, adjustment for cardiovascular risk factors abolished this association.
Conclusions: Measurement of serum RBP4 does not provide added value for predicting CAD risk beyond traditional risk factors.
This article has been cited by other articles:
![]() |
E. Ingelsson and L. Lind Circulating Retinol-Binding Protein 4 and Subclinical Cardiovascular Disease in the Elderly Diabetes Care, April 1, 2009; 32(4): 733 - 735. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |